A Double-Blind, Randomized, Dose-Controlled Study to Evaluate Pharmacodynamic Properties of Four Oral Doses of Dienogest (DNG) in 100 Healthy Young Female Volunteers Over a Period of Two Cycles up to a Maximum of 72 Days.

Trial Profile

A Double-Blind, Randomized, Dose-Controlled Study to Evaluate Pharmacodynamic Properties of Four Oral Doses of Dienogest (DNG) in 100 Healthy Young Female Volunteers Over a Period of Two Cycles up to a Maximum of 72 Days.

Completed
Phase of Trial: Phase I

Latest Information Update: 05 Feb 2015

At a glance

  • Drugs Dienogest (Primary)
  • Indications Pregnancy
  • Focus Pharmacodynamics
  • Sponsors Bayer
  • Most Recent Events

    • 23 Sep 2009 Actual patient number (199) added as reported by ClinicalTrials.gov.
    • 23 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 08 Jul 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top